66 results
Page 3 of 4
8-K
EX-10.1
h0cabzl
26 Nov 18
Other Events
9:01am
425
EX-10.1
374fbkp2e62olpy
26 Nov 18
Business combination disclosure
8:59am
DEFM14A
w8im4
6 Nov 18
Proxy related to merger
12:00am
424B3
oicmi3n
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
5abt4 5wlbu1
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.6
w1v 18trz
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
612 1u8iwl
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
5s2u8by lbai
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-99.1
1dxss
13 Jun 13
OvaScience Appoints Mary Fisher to Company’s Board of Directors
12:00am
424B3
mmq1cxk1ts0u5
13 Jun 13
Prospectus supplement
12:00am
424B3
s96knn6w5ls
13 Jun 13
Prospectus supplement
12:00am
D
xnv53
28 Mar 13
$35M in equity, sold $35M, 31 investors
12:00am
10-K
wvpavdy
25 Feb 13
Annual report
12:00am